TAVISCORE: a computer program for risk stratification of complications after aortic valve interventions in patients with reduced ejection fraction

Aim. To demonstrate the TAVISCORE program designed to stratify the risk of complications after aortic valve (AV) interventions in patients with reduced ejection fraction.

Material and methods. For the period from 2015-2022 at the Almazov Federal North-West Medical Research Center, 128 interventions on AV were performed for aortic stenosis in patients with reduced ejection fraction as follows: 61 — surgical AV replacement (SAVR), 67 — transcatheter aortic valve implantation (TAVI). To create an interactive calculator TAVISCORE (link for free download: https://drive.google.com/file/d/1a3s2MK6Tpk0cIQ_aMB7xe63upEwJsJOh/view?usp=sharing) all patients were combined into one group. For each factor present in the patient, the prognostic coefficient, its contribution to the likelihood of an event in the long-term follow-up period (death, myocardial infarction, stroke), was calculated. The next step, based on the calculations obtained and using the Python 3.10.6 language, was the creation of the TAVISCORE program.

Results. The TAVISCORE was created for the personalized choice of tactics for the treatment of patients with aortic stenosis. It contains 54 risk factors and makes it possible to determine probability of cardiac or non-cardiac events in the long-term follow-up period after SAVR and TAVI. Thus, a tactic with lower probability of a complication can be chosen as optimal in this particular case. Retrospective use of the TAVISCORE after surgery can identify patients at high risk of complications, which will allow them to be selected for more thorough management and more frequent screening.

Conclusion. The TAVISCORE can be used by a multidisciplinary consensus to select the treatment tactics and stratify the risk of complications after different AV replacement variants in patients with a reduced ejection fraction. Further prospective testing of this program is required. 

1. Sá MP, Jacquemyn X, Tasoudis PT, et al. Immediate and late outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in bicuspid valves: Meta-analysis of reconstructed time-to-event data. J Card Surg. 2022;37(10): 3300-10. doi:10.1111/jocs.16840.

2. Sá MP, Sun T, Fatehi Hassanabad A, et al. Complete transcatheter versus complete surgical treatment in patients with aortic valve stenosis and concomitant coronary artery disease: Study-level meta-analysis with reconstructed time-to-event data. J Card Surg. 2022;37(7):2072-83. doi:10.1111/jocs.16511.

3. Chernyavsky MA, Strelkov DA, Zubarev DD, et al. Open prosthetics or transcatheter aortic valve implantation? Russian medical journal. 2021;27(2):153-62. (In Russ.). doi:10.17816/0869-2106-2021-27-2-153-162.

4. Kazantsev AN, Khasanova DD, Alpatskaya AD, et al. CAROTIDSCORE.RU — risk stratification of complications after carotid endarterectomy. Russian Journal of Cardiology. 2022;27(5):5031. (In Russ.). doi:10.15829/1560-4071-2022-5031.

5. Kazantsev AN, Tarasov RS, Burkov NN, Ganyukov VI. Hybrid revascularization of the brain and myocardium: stratification of the risk of hospital complications. Angiology and vascular surgery. 2020;26(2):118-23. (In Russ.). doi:10.33529/ANGIO2020212.

6. Kazantsev AN, Vinogradov RA, Erofeev AA. The problem of choosing the method of revascularization in case of combined lesions of the coronary and carotid arteries. Review of current recommendations and a series of articles. Emergency medical care. N.V. Sklifosovsky Journal. 2022;11(1):147-57. (In Russ.). doi:10.23934/2223-9022-2022-11-1-147-157.

7. Zakeryaev AB, Vinogradov RA, Sukhoruchkin PV. Comparative results of various methods of autologous femoral-popliteal vein bypass using a propensity score matching analysis. Surgery. N. I. Pirogov Journal. 2022;10:44-50. (In Russ.) doi:10.17116/hirurgia202210144.

8. Prokhorikhin AA, Tarkova AA, Zubarev DD, et al. Surgical aspects and results of a singlecenter prospective register of transcatheter aortic valve implantation. Russian Journal of Cardiology. 2018;(11):77-82. (In Russ.) doi:10.15829/1560-4071-2018-11-77-82.

9. Tarasov RS, Kazantsev AN, Shabaev IF, et al. Results of expedient incomplete myocardial revascularization using minimally invasive and standard coronary artery bypass grafting techniques. Russian Journal of Cardiology. 2018;(7):47-52. (In Russ.). doi:10.15829/1560-4071-2018-7-47-52.

10. Bazylev VV, Voevodin AB, Shalygina AS. Mid-term results of transcatheter implantation of aortic valve prosthesis "MedLab-CT". Russian Journal of Cardiology. 2019;(8):65-9. (In Russ.). doi:10.15829/1560-4071-2019- 8-65-69.